AstraZeneca PLC is 204.0x more valuable than Harrow, Inc. by market capitalization ($286.27 B vs $1.40 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HROW | AZN |
|---|---|---|
| Market cap | $1.40 B | $286.27 B |
| US-listed rank | #2394 | #47 |
| Revenue (latest FY) | $272.30M | - |
| Net income (latest FY) | -$5.14M | - |
| Net margin | -1.9% | - |
| SEC filings | 849 | 1,004 |
AstraZeneca PLC is 204.0x more valuable than Harrow, Inc. by market capitalization ($286.27 B vs $1.40 B).
Full pages: Harrow, Inc. and AstraZeneca PLC, or browse the full rankings.